PKCδ signalling regulates SR-A and CD36 expression and foam cell formation.
about
PKCδ-IRAK1 axis regulates oxidized LDL-induced IL-1β production in monocytes.PKCδ promotes high glucose induced renal tubular oxidative damage via regulating activation and translocation of p66Shc.Vasoprotective effects of urocortin 1 against atherosclerosis in vitro and in vivo.Current siRNA targets in atherosclerosis and aortic aneurysm.The phosphoinositide 3-kinase signaling pathway is involved in the control of modified low-density lipoprotein uptake by human macrophagesAmelioration of Hyperglycemia with a Sodium-Glucose Cotransporter 2 Inhibitor Prevents Macrophage-Driven Atherosclerosis through Macrophage Foam Cell Formation Suppression in Type 1 and Type 2 Diabetic Mice.Gentiana scabra Reduces SR-A Expression and Oxidized-LDL Uptake in Human Macrophages.Thrombomodulin regulates monocye differentiation via PKCδ and ERK1/2 pathway in vitro and in atherosclerotic artery.Nicotine potentiates proatherogenic effects of oxLDL by stimulating and upregulating macrophage CD36 signaling.DPP-4 inhibitors repress foam cell formation by inhibiting scavenger receptors through protein kinase C pathway.Activation of soluble guanylyl cyclase prevents foam cell formation and atherosclerosis.Curcuminoids distinctly exhibit antioxidant activities and regulate expression of scavenger receptors and heme oxygenase-1.Effects of citrus flavonoids, 5-hydroxy-3,6,7,8,3',4'-hexamethoxyflavone and 3,5,6,7,8,3',4'-heptamethoxyflavone, on the activities of macrophage scavenger receptors and the hepatic LDL receptor.Identification of a novel series of anti-inflammatory and anti-oxidative phospholipid oxidation products containing the cyclopentenone moiety in vitro and in vivo: Implication in atherosclerosis.Macrophage-Associated Lipin-1 Enzymatic Activity Contributes to Modified Low-Density Lipoprotein-Induced Proinflammatory Signaling and Atherosclerosis.Monocyte Recruitment Versus Macrophage Proliferation in Atherosclerosis.Neopterin Counters Vascular Inflammation and Atherosclerosis.IRAK regulates macrophage foam cell formation by modulating genes involved in cholesterol uptake and efflux.Atorvastatin inhibits CD68 expression in aortic root through a GRP78-involved pathway.
P2860
Q33825045-70E6C1CD-C382-402D-92B5-B364F4460FF7Q34412593-F40C1AF2-CE9E-4992-B715-E10BC5A00E57Q34610945-605C3F84-A904-47E9-9603-6E6DA5C4CE75Q34966954-C67B852E-B01B-40CB-86B3-24F8E4880589Q35557995-BEA1B8D2-6348-4728-AEB5-FE25AFEFC4AEQ35852679-9EE4741D-6839-46BE-A128-37EBFCE81CEBQ37131824-F8FCC6D3-52CC-4D66-8F28-7BD28FC4DEB6Q37464993-1D4C2948-B610-4D96-9119-1B74E1F999C4Q37476547-4D14D3FA-3114-49C2-9C05-5A3CACB0AC98Q39040954-640E0688-73E6-4F7E-9911-9EE6E8C8ADA7Q39050535-7E1838A1-2418-4F3C-A84F-47F3DB410088Q39198823-06BB00F5-8461-4F2D-8BEC-38E18FF2F3DCQ39201287-152A02DE-4D34-4FE0-AD6E-451C7D69C74EQ42775756-8D2EDCF8-D909-4211-AE85-0D23AD233C31Q46105279-59CC8402-45BE-4B64-9FB6-7B7F6C6F54F3Q47598516-AE7356A8-6235-49D1-A6C1-692401219EBDQ50115901-742243AF-5DDC-4B03-91F5-EBF996F634A6Q51716488-E3008B9F-FB22-401F-8F3A-095FA3CCFF0CQ51746469-0B0DF163-87D8-491A-995B-C5EB8C3B65FD
P2860
PKCδ signalling regulates SR-A and CD36 expression and foam cell formation.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
PKCδ signalling regulates SR-A and CD36 expression and foam cell formation.
@en
PKCδ signalling regulates SR-A and CD36 expression and foam cell formation.
@nl
type
label
PKCδ signalling regulates SR-A and CD36 expression and foam cell formation.
@en
PKCδ signalling regulates SR-A and CD36 expression and foam cell formation.
@nl
prefLabel
PKCδ signalling regulates SR-A and CD36 expression and foam cell formation.
@en
PKCδ signalling regulates SR-A and CD36 expression and foam cell formation.
@nl
P2093
P2860
P356
P1476
PKCδ signalling regulates SR-A and CD36 expression and foam cell formation
@en
P2093
Chen-Hao Lian
Chien-Sung Tsai
Chin-Sheng Lin
Chuan-Yueh Huang
Feng-Yen Lin
Jenn-Haung Lai
Shih-Ping Yang
Shu-Mung Cheng
Wan-Lin Wu
P2860
P304
P356
10.1093/CVR/CVS189
P50
P577
2012-06-11T00:00:00Z